Negotiation Skills and Selling Strategies

Beckton Dickson Case Study: Negotiation Strategy

Becton Dickinson (BD) is recognized as a large family-owned concern with HQs in New Jersey that highlights diagnostic devices and healthcare. Establishment in 1897, Becton Dickinson has proven its status founded on a paternalistic human resource viewpoint, e.g. rewards loyalty and never fires anyone (Currie, 2006). In 1981, things had become different when Roger Kern was selected as the vice president of human resources. Kern managed to create a first-class traditional HR purpose at Becton Dickinson that emphasized on compensation, education, benefit and other important HR purposes. Throughout the late 1980s, in spite of these significant changes, difficulties started coming to the surface. Ever more workers protested most functions and HR programs were "less than operative," "not truthful enough" or "unfeeling to specific needs', and numerous managers started to feel that Kern was not successful when it came to assembling a strong business-oriented staff of business HR specialists (Buzzell, 1993).

The Plan for Negotiations

After carefully studying both my side as a worker, and the other side it was important to come up with some kind of Best Alternative To a Negotiated Agreement (BATNA) plan. It is clear from the case that the following needs to be addressed in order for everyone to be happy:

Bring down the prices of all the tubes and needles

Provide all of the "private label tubes" and also the needles to APG

Provide needles and tubes to APG via APG associated distributors

What is the Best Alternative To a Negotiated Agreement (BATNA)

BD is presently in a difficult position where they have to make a decision on whether or not they should lower their prices to obey with the APG or remain as they are doing at the moment. Beckton Dickson is standing to lose a lot of business for the reason that APG wants to set a sample of the blood collection preparations. It appears that the managers do not seem to have any thorough responsiveness in the excellence of the blood system gatherings nonetheless simply in the worth. The best alternative since Terumo proposed prices that were 20% lower than Beckton Dickson's is to go with the 20%. Also it would be wise for Beckton Dickson to negotiate with APG by going along with the things that they stressed on. For example, APG's other strains which included that supplies would turn into things that would be considered private brand and use single definite suppliers, would mean that Beckton Dickson would help APG with these brands and suppliers. The demand that merely particular distributors would be sanctioned to source APG could be devastating for the association of Beckton Dickson with the rest of its distribution network would be changed through this negotiation. It is clear the Beckton Dickson has a bad name because of their past but in order to negotiate they are going to have to change their image by compromising with their competitor company which is something that they would have never done in the past.

In the past companies that settled with this demand had been released by the large distributors which hurt their business hugely. This left Beckton Dickson in a bad and tough situation. However, to negotiate they will now do things much differently by complying with the demands of distributors like APG or it is clear that they will lose them. Beckton Dickson will have to make some huge decision by cutting their ties with ASP in order to do better business with APG.

Possible Solutions

Don't engage in the contract and aggressively try to preserve the contracts with present APG-hospitals. The agreement will go to Terumo and Terumo could possibly stand to misplace the support of their key distributors. If this occurs Terumo's current marketplace share is susceptible and BD can violently go after these contracts by outspending Terumo. Beckton Dickson is capable of doing this for the reason that it has the biggest marketplace share and the bottommost rate expense per unit. If this resolution is successful Beckton Dickson could end up with about 90% marketplace share even though Terumo would end up with a 10% marketplace segment with a profit margin that is very low. This nonetheless necessitates an excellent association with the suppliers that are at present supporting Terumo and may include increasing the gross margin for the suppliers to tempt them to get rid of Terumo as a client. Other ways to make the relationship among Beckton Dickson and the distributor is by encouraging to increase the gross margins on Beckton Dickson products of other Beckton Dickson divisions.

Another thing would be to -pursue the contract, agree to everyone of the demands, and then bring down the price so that it will be at the exact level as Terumo. This will make sure that Beckton Dickson will get the contract for the reason that they have developed quality products. In combination with the contract Beckton Dickson would need try and stay on the lists of all the distributors that were not involved in the contract. This can be done likely increasing the aggregate margins on Beckton Dickson merchandises or by intimidating to remove everyone of Beckton Dickson merchandises from the distributor. If everyone of the distributors can be persuaded to keep Beckton Dickson as a customer this could be the best answer nevertheless the likelihood continues that distributors will drop Beckton Dickson as a client. If this occurs the customers will need to be enticed to change suppliers by means of lower prices and the assurance of quality that is high than competitor merchandises. This can be accomplished for the reason that Beckton Dickson has the lowest cost price per unit and the uppermost quality. If this explanation is acknowledged the APG contract is safeguarded and at least 10% marketplace share now fits to Beckton Dickson for the predictable future. This solution likewise has the maximum risk enclosed to it if suppliers like ASP choose to drop Beckton Dickson as a client.

Another thing to do for negotiations would be to pursue the contract, bring the price down to the competitor's level, then receive the private label demand, and then go and try to persuade APG to use Beckton Dickson distributors. This key delivers the best choice for the distributors. In this case the distributors are happy for the reason that they are not insulted by Beckton Dickson, Beckton Dickson does have a large contract with 500 of the most dominant hospitals, and APG has the best excellence products for the similar cost as the competitor's products. Nevertheless APG might throwaway this proposal as they made the point that they sought to be provided through APG associated distributors. If this explanation is followed the contract could or could not take place. If the contract is acknowledged Beckton Dickson has increased its marketplace share and secured the association with most of the distributors. Nevertheless if the contract is disallowed Beckton Dickson has reserved the association with the distributors and can violently chase to preserve the agreements with hospitals that are presently under the APG-umbrella.

The researcher would recommend that Beckton Dickson does not chase the APG-agreement. By not chasing the agreement they keep in good relationships with their suppliers and can open up an aggressive on Terumo who will obtain the contract. However, Terumo's recognition of the APG agreement demotes ASP, a supplier that provides 70% of Temuro's present sales. If Beckton Dickson is capable to persuade ASP to drop Temuro as a buyer or if ASP chooses to do this on its own accord in order to send some kind of message the market share of Temuro is vulnerable.

This gives Beckton Dickson a chance to belligerently follow Temuro's customer contracts that were outside of APG. By dropping its values to Temuro's level and encouraging a quality that is greater which Beckton Dickson is capable of doing by utilizing its market share to cut the cost that is going on per unit. This policy of aggressively pursuing every agreement that is outside of APG and trying to uphold the agreements that are with individual APG hospitals could guarantee the development of market share in spite of the likely loss of the contract. Now if this plan is fruitful Beckton Dickson market share would upturn while Terumo would more than likely be stuck with an agreement with a very low edge.

This strategy is considered to have the biggest pay-off if key supplier like ASP could be persuaded to drop Temuro as one of their a clients. Attaining this may necessitate some motivations like raising the gross margin on Beckton Dickson products. Nevertheless this could not be essential for the reason that the key distributors will feel affronted by Temuro's choice to sideline them and this only could be an influential enticement for them to display to other constructors that they will not stand being put aside. If Beckton Dickson realizes to improve associations with the suppliers they may even be able to influence them to act in their courtesy by compelling them to make a sample of Temuro or by encouraging higher gross margins and lesser fees than Temuro. The mixture of the superior quality of Beckton Dickson products, greater margins, lower prices, and the feeling of being shelved by Temuro could be enough to lure the major distributors to exclusively dispense Beckton Dickson products.

Further the researcher believes that Beckton Dickson would need to try to contest with the other players on the needle marketplace as they have been dropping marketplace share for the past few years. Our suggested solution can be abridged as the following: Focusing on association with key suppliers, open offensive on Terumo contracts, and raise rivalry in the needle market.

1. 1983 -- BDVS fought negotiation. Why?

Firs it is important to find out why the negotiation was fought in the first place. In 1983, APG required substantial price decreases from the BDVS. However, during that time BDVS was not willing to do these price decreases because of its superior excellence, service and range and service and fought against the negotiation with the APG HQ. The following are some of the key motives behind why BDVS resisted negotiations.

a. BDVS turned out to be a pioneer in altering the market of Blood Collection Products Market to Evacuated-Tube Blood collection method from Needle & Syringe method. BDVS had the broadest array of blood collection products and this was vital for the Hospitals, which are on this to run numerous diagnostic tests for hematology, chemistry, coagulation studies, special procedures and blood banking. Product variety / color coding schemes accessible by BDVS were favored by the customers (Baiada-hireche, 2012).

b. Blood collection products shaped merely 6% of the entire supplies bought by hospitals and the BDVS products were favored by the "bench individuals" in the laboratory (medical specialists in the lab) for its quality / range (Christopher A. Bartlett, 2012).

c. It was not required on the APG associate hospitals to purchase merely from the negotiated manufacturer for the creation. Founded on the partialities of the "bench individuals," they could purchase from a different salesperson as well (Currie, 2006). Taking benefit of this direction, BDVS sustained selling trustily to Individual hospitals by means of its well-progressive field sales force that conserved good associates with their customers that were current and was accomplished to resist the share of marketplace. Wherever expense had become it kept most of its industry with hospitals that were separate (that were connected with APG) by means of prices reduced, on a case-to-case foundation. So they did not have a convincing necessity to approach the negotiation bench (Zuzulock, 2006).

d. For the past few years, BDVS had put in place the "Z Contract" with its large and key Accounts after cooperation for quantities and price supplied to them through its official suppliers.

2. 1985 -- BDVS ready for negotiation. Why?

BDVS was ready for negotiation with APG due to the following particulars:-

Changing Market Trends:

1. In the United States, 1800 key hospitals had been accounted for 60% of the marketplace for equipment and medical supplies. Similarly 70% of most of the blood tests had been done inside of the Hospitals in the United States (Baiada-hireche, 2012).

2. In 1983, the United States government moved in new legislative for the re-expenditure of costs for Medicare patients originated on examination -- associated Groups (DRG) and not on prices for hospital. It was clear that the hospitals did pick to choice to control costs and look at things otherwise and henceforth the hospitals fortified individuals to choose for day care amenities rather than comply.

This had a dramatic effect in expressions of decrease in the hospital admittances by 5%, period of days had fallen by 5% and the amount of hospital beds as well were predicted to fall in the 1990 by 34%. All of this was saying that the marketplace was dwindling and that there is a necessity to defend this dwindling marketplace. The BDVS want to uphold its portion in this market, bearing in mind this future trend and APG was developing as one of the influential buying groups to calculate with. BDVS made the decision to negotiate with APG.

3. Because of the above DRG-based re-imbursements, there was cumulative cost repression stress on the hospitals to make sure that the cost was brought down cost of its purchases, administration and maintenance. This is another motive for the separate hospitals -- large or small -- to get connected to buying groups like APG in order to acquire a price advantage for integrated purchasing of merchandises.

Changing Buying Behavior:

1. now the buyer has altered from being the Lab personnel, and this was a person that was familiar with the company and also the product representative to the Purchasing Personnel that has come from various circumstances. These individuals required steady service nevertheless with lower prices.

2. Buying has begun from Corporate Purchasing from Hospital purchasing for huge national multi-chains of hospital. These either negotiated straight with Builders like BDVS or linked themselves to Purchasing Groups such as APG, which had better buying power because of high capacities.

Emergence of APG as a strong Purchasing Entity:

1. Increasing amount of hospitals were getting associated to APG. From 24 hospitals during the year of 1972, the current affiliation stood at 500 hospitals. A lot of the prestigious and large hospitals allied with medical schools were now APG associates.

2. APG's power was getting much bigger and also its purchasing power. APG was having national purchasing contracts with about 100 medical apparatus dealers and the numbers of such arrangements were progressively growing in the current years.

3. During the year of 1983, as BDVS were not yielding to APG for the reduction in price, APG decided to enter some kind of a national purchasing arrangement with Terumo, who is their competitor.

4. APG, after BDVS fought against negotiations in 1983, introduced a group of field personnel who were going to its member hospitals for operation of the agreements and they had went to marketing that was negative which ensued in pampering of association of BDVS with its clienteles. After BDVS had a get together with APG HQ affiliates after this incident, the relationship got much better at particular hospitals.

5. APG in 1985, had proclaimed its choice to start its own delivery system and throughout the year it had taken in its fold numerous regional and small distributors that were into medical products delivery to trucking/billing and warehouse operations to APG-associated Hospitals.

6. APG was advertising to its member hospitals that through its program hospital prices could be transported down by 5% to 14% on a lot of the supply items.

7. APG's Material Administration was belligerently marketing the distribution programs and private label. Those suppliers that did not contribute in these programs were not given any type of APG contracts.

8. During April 1985, Mr. Wilson, VP -- MM at APG made an announced that they were going to establish a new national buying contract for the blood collection merchandises. The Supplier that showed the will accept 90% of the order for such items that are from APG associated hospitals. Even though this was not accurate, as per the sales individual's field assessment, nonetheless considerable share of the industry with these hospitals was at danger.

9. APG was grim in regards to purchasing contract and did whatever they had to do in order to make sure this contract would be successful.

10. It is obvious that the stakes of BDVS were great as at the APG connected hospitals it had a portion of 80% of their intravenous blood collection tubes and 50% segment for the needles. In the end, it would sum up to U.S.$6 Million in sales to these hospitals in 1984.

11. APG was likewise negotiating with BDVS participants.

As mentioned from the above, BDVS supervision felt it sensible to not struggle against negotiation and made the decision to negotiate openly with PG HQ.

3. Aug 15, 1985 -- What should BDVS propose? Why?

Part of the plan is understanding what needs to be done in regards to BDVS. One thing to remember BDVS had sales of $ 90Mn in 1984 and each of its product group accounted for 33% of its operating income.

Out of this, as sales of $6Mn had come from APG affiliated hospitals last year and this is roughly 7% of its sales revenue. Its closest competitor Terumo is at its heels and had been pricing aggressively to gain market share. Hence, BDVS should not ignore this requirement from APG.